Augmentation effect of postprandial hyperinsulinaemia on growth of human hepatocellular carcinoma

Gut

Volumn 51, Issue 1, 2002, Pages 100-104

  Saito, K ^a   Inoue, S ^b   Saito, T ^a   Kiso, S ^b   Ito, N ^b   Tamura, S ^b   Watanabe, H ^a   Takeda, H ^a   Misawa, H ^a   Togashi, H ^a   Matsuzawa, Y ^b   Kawata, S ^a,b  

^a YAMAGATA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; OCTREOTIDE;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CANCER GROWTH; CONTINUOUS INFUSION; FEMALE; GLUCOSE METABOLISM; GLUCOSE TOLERANCE TEST; GROWTH RATE; HUMAN; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL;

AREA UNDER CURVE; BLOOD GLUCOSE; CARCINOMA, HEPATOCELLULAR; FEMALE; GLUCOSE TOLERANCE TEST; HORMONES; HUMANS; HYPERINSULINISM; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OCTREOTIDE; POSTPRANDIAL PERIOD; SOMATOSTATIN;

EID: 0036296994     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.51.1.100     Document Type: Article

References (30)

1. Hepatocellular carcinoma: Recent progress
2. Glucose tolerance and diabetes in chronic liver disease
3. Cirrhosis and diabetes. Increased incidence of diabetes in patients with Laennec's cirrhosis. I
4. Cirrhosis and diabetes. Association of impaired glucose tolerance with potal-systemic shunting in Laennec's cirrhosis
5. Glucose metabolism in liver cirrhosis
6. Hyperinsulinism of hepatic cirrhosis: Diminished degradation or hypersecretion?
7. Glucose metabolism in cirrhosis: A review with some perspectives for the future
8. Effect of physiologic hyperinsulinemia on glucose and lipid metabolism in cirrhosis
9. Growth rate of asymptomatic hepatocellular carcinoma and its clinical implication
10. Small hyperechoic nodules in chronic liver diseases include hepatocellular carcinomas with low cyclin D1 and Ki-67 expression
11. Natural history of minute hepatocellular carcinoma smaller than three centimeter complicating cirrhosis. A study of 22 patients
12. Natural history of small untreated hepatocellular carcinoma in cirrhosis: A multivariate analysis of prognostic factors of tumor growth rate and patient survival
13. Serial hemodynamic measurements in well-differentiated hepatocellular carcinomas
14. The origin, hormonal nature, and action of hepatotrophic substances in portal venous blood
15. Expression and phosphorylation of insulin receptor substrate 1 during rat liver regeneration
16. Treatment of hepatocellular carcinoma with octreotide: A randomized controlled study
17. Insulin resistance in cirrhosis: Prolonged reduction of hyperinsulinemia normalizes insulin sensitivity
18. Classification and diagnosis of diabetes mellitus and other categories intolerance
19. Glucose and insulin metabolism in cirrhosis
20. Contribution of reduced insulin sensitivity and secretion to the pathogenesis of hepatogenous diabetes: Effect of liver transplantation
21. Glucose intolerance and insulin resistance in cirrhosis are normalized after liver transplantation
22. Effect of spontaneous portal-systemic shunting on insulin metabolism
23. Insulin receptor substrate 1 is required for insulin-mediated mitogenic transduction
24. The function of GRB2 in linking the insulin receptor to Ras signaling pathways
25. A carboxy-terminal truncated insulin receptor substrate-1 dominant negative protein reverses the human hepatocellular carcinoma malignant phenotype
26. Insulin as a potent, specific growth factor in a rat hepatoma cell line
27. Expression of insulin-like growth factor-like growth factor-II, alpha-fetoprotein and hepatitis B virus transcripts in human primary liver cancer
28. Increased expression of the insulin-like growth factor I (IGF-1) receptor gene in hepatocellular carcinoma cell lines; implications of IGF-1 receptor gene activation by hepatitis B virus X gene product
29. Localization of insulin-like growth factor-II and hepatitis B virus mRNAs and proteins in human hepatocellular carcinomas
30. Somatostatin analog induces insulin-like growth factor binding protein-1 (IGFBP-1) expression in human hepatoma cells